MENU
+Compare
CRSP
Stock ticker: NASDAQ
AS OF
Jun 6 closing price
Price
$41.86
Change
+$3.29 (+8.53%)
Capitalization
3.62B

CRSP CRISPR Therapeutics AG Forecast, Technical & Fundamental Analysis

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CRSP with price predictions
Jun 06, 2025

Momentum Indicator for CRSP turns positive, indicating new upward trend

CRSP saw its Momentum Indicator move above the 0 level on June 05, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned positive. In of the 95 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CRSP just turned positive on June 03, 2025. Looking at past instances where CRSP's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

CRSP moved above its 50-day moving average on June 03, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CRSP crossed bullishly above the 50-day moving average on May 27, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRSP advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRSP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CRSP broke above its upper Bollinger Band on June 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CRSP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.976) is normal, around the industry mean (16.648). P/E Ratio (0.000) is within average values for comparable stocks, (59.923). CRSP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.234). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (102.041) is also within normal values, averaging (260.036).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRSP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CRSP is expected to report earnings to fall 9.49% to -142 cents per share on August 11

CRISPR Therapeutics AG CRSP Stock Earnings Reports
Q2'25
Est.
$-1.43
Q1'25
Missed
by $0.37
Q4'24
Beat
by $0.79
Q3'24
Beat
by $0.37
Q2'24
Missed
by $0.06
The last earnings report on May 06 showed earnings per share of -158 cents, missing the estimate of -121 cents. With 4.73M shares outstanding, the current market capitalization sits at 3.62B.
A.I. Advisor
published General Information

General Information

a developer of gene-based medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Baarerstrasse 14
Phone
+41 415613277
Employees
407
Web
https://www.crisprtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWJCX105.10N/A
N/A
Nationwide NYSE Arca Tech 100 Idx A
DEIGX11.22N/A
N/A
MassMutual Disciplined Gr Svc
LIMIX7.90N/A
N/A
Cromwell Tran Sustainable Focus Instl
MTRBX19.23N/A
N/A
MFS Total Return B
MBVKX19.89N/A
N/A
BlackRock Large Cap Focus Value K

CRSP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+8.53%
RXRX - CRSP
73%
Closely correlated
+20.13%
BEAM - CRSP
72%
Closely correlated
+9.26%
NTLA - CRSP
66%
Loosely correlated
+6.73%
PRME - CRSP
64%
Loosely correlated
+24.26%
ABCL - CRSP
63%
Loosely correlated
+2.95%
More

Groups containing CRSP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+8.53%
CRSP
(4 stocks)
94%
Closely correlated
+11.16%